HCPCS Code J7620

Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
Code effective Jan 01, 2007

HCPCS Section
Drugs administered other than oral method, chemotherapy drugs

J7620 is a valid 2026 HCPCS code meaning Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme or (Albuterol ipratrop non-comp) for short. HCPCS J7620 has been effective since 01/01/2007 and applies to Medical care.


HCPCS Code Details - J7620

HCPCS Level II Code
Section J - Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J7620
Description

Long description:
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme

Short description:
Albuterol ipratrop non-comp

HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code D - Special coverage instructions apply
BETOS2 code D1G - Drugs Administered through DME
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jan 01, 2007
Date added Added Jan 01, 2006

See also

  • HCPCS J7615 · Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg

  • HCPCS J7622 · Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”


HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.